Emerging computational paradigms to address the complex role of gut microbial metabolism in cardiovascular diseases

Front Cardiovasc Med. 2022 Oct 10:9:987104. doi: 10.3389/fcvm.2022.987104. eCollection 2022.

Abstract

The human gut microbiota and its associated perturbations are implicated in a variety of cardiovascular diseases (CVDs). There is evidence that the structure and metabolic composition of the gut microbiome and some of its metabolites have mechanistic associations with several CVDs. Nevertheless, there is a need to unravel metabolic behavior and underlying mechanisms of microbiome-host interactions. This need is even more highlighted when considering that microbiome-secreted metabolites contributing to CVDs are the subject of intensive research to develop new prevention and therapeutic techniques. In addition to the application of high-throughput data used in microbiome-related studies, advanced computational tools enable us to integrate omics into different mathematical models, including constraint-based models, dynamic models, agent-based models, and machine learning tools, to build a holistic picture of metabolic pathological mechanisms. In this article, we aim to review and introduce state-of-the-art mathematical models and computational approaches addressing the link between the microbiome and CVDs.

Keywords: agent-based modeling; cardiovascular diseases; genome-scale metabolic model; microbiome; spatiotemporal dynamics; systems biology.

Publication types

  • Review